InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,735.20
(
0.07%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.09
(
-0.14%
)
Bitcoin
61,846.26
(
-1.68%
)
Post# of 458964
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

plexrec

Send PM Follow Ignore
Followers 32
Posts 6391
Boards Moderated 0
Alias Born 01/20/2016

plexrec

Re: None

Sunday, 02/03/2019 10:30:21 AM

Sunday, February 03, 2019 10:30:21 AM

Post# of 458964
Just came upon this from Adis Insights--(drug profile) re:2-73---interesting to see MS shown to be in "pre-clinical" also a reference to Anavex planning for development (a trial) for Epilepsy in Germany---both news to me----https://adisinsight.springer.com/drugs/800033840 comments ????
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!